Brain and brawn - Parallels in oxidative strength

被引:36
作者
Moreira, PI
Honda, K
Zhu, X
Nunomura, A
Casadesus, G
Smith, MA
Perry, G
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, P-3000 Coimbra, Portugal
[3] Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 078, Japan
关键词
D O I
10.1212/01.wnl.0000192307.15103.83
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuronal oxidative stress occurs early in the progression of Alzheimer disease ( AD), significantly before the development of the pathologic hallmarks, neurofibrillary tangles, and senile plaques. Study of Down syndrome, cases with autosomal dominant mutation, and sporadic AD all suggest amyloid-beta deposition and hyperphosphorylated tau function as compensatory responses and downstream adaptations to ensure that neuronal cells do not succumb to oxidative damage. Amyloid-beta and tau hyperphosphorylation also define vulnerable muscle cells in sporadic inclusion-body myositis (s-IBM). The role of the structural changes of s-IBM, as in AD, remains to be determined but may mark a critical response yielding a novel balance in oxidant homeostasis.
引用
收藏
页码:S97 / S101
页数:5
相关论文
共 56 条
[1]   Novel immunolocalization of α-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions [J].
Askanas, V ;
Engel, WK ;
Alvarez, RB ;
McFerrin, J ;
Broccolini, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (07) :592-598
[2]   Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease. [J].
Askanas V. ;
Engel W.K. .
Current Rheumatology Reports, 2002, 4 (5) :427-433
[3]   Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation [J].
Cash, AD ;
Aliev, G ;
Siedlak, SL ;
Nunomura, A ;
Fujioka, H ;
Zhu, XW ;
Raina, AK ;
Vinters, HV ;
Tabaton, M ;
Johnson, AB ;
Paula-Barbosa, M ;
Avila, J ;
Jones, PK ;
Castellani, RJ ;
Smith, MA ;
Perry, G .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1623-1627
[4]   Role of mitochondrial dysfunction in Alzheimer's disease [J].
Castellani, R ;
Hirai, K ;
Aliev, G ;
Drew, KL ;
Nunomura, A ;
Takeda, A ;
Cash, AD ;
Obrenovich, ME ;
Perry, G ;
Smith, MA .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) :357-360
[5]   Active glycation in neurofibrillary pathology of Alzheimer disease:: Nε-(carboxymethyl) lysine and hexitol-lysine [J].
Castellani, RJ ;
Harris, PLR ;
Sayre, LM ;
Fujii, J ;
Taniguchi, N ;
Vitek, MP ;
Founds, H ;
Atwood, CS ;
Perry, G ;
Smith, MA .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (02) :175-180
[6]  
GAMBETTI P, 1994, AM J PATHOL, V145, P1261
[7]   AGING - A THEORY BASED ON FREE-RADICAL AND RADIATION-CHEMISTRY [J].
HARMAN, D .
JOURNALS OF GERONTOLOGY, 1956, 11 (03) :298-300
[8]   Mitochondrial abnormalities in Alzheimer's disease [J].
Hirai, K ;
Aliev, G ;
Nunomura, A ;
Fujioka, H ;
Russell, RL ;
Atwood, CS ;
Johnson, AB ;
Kress, Y ;
Vinters, HV ;
Tabaton, M ;
Shimohama, S ;
Cash, AD ;
Siedlak, SL ;
Harris, PLR ;
Jones, PK ;
Petersen, RB ;
Perry, G ;
Smith, MA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (09) :3017-3023
[9]   Oxidative stress and redox-active iron in Alzheimer's disease [J].
Honda, K ;
Casadesus, G ;
Petersen, RB ;
Perry, G ;
Smith, MA .
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 :179-182
[10]   Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis [J].
Horvath, R ;
Fu, K ;
Johns, T ;
Genge, A ;
Karpati, G ;
Shoubridge, EA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05) :396-403